Item 2.02 Results of Operations and Financial Condition

On August 12, 2020, Neoleukin Therapeutics, Inc. (the "Company") issued a press release announcing financial results for the quarter ended June 30, 2020. The full text of the press release announcing such results is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this current report on Form 8-K and the press release attached as Exhibit 99.1 hereto is being furnished, but shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), and is not incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits



 Number   Description

 99.1       Press Release of Neoleukin Therapeutics, Inc. dated August 12, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses